Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults. ...
Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday. ...
The Supreme Court on Monday posted for next week the hearing on Yoga guru Ramdev's plea against the registration of multiple FIRs against him in various states over his alleged remarks on the efficacy of allopathy in COVID-19 treatment. ...
Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday. ...